Astra Zeneca Pharma India Ltd Q1FY23 profit drops QoQ to Rs. 20.15 crores

AstraZeneca Pharma India Limited has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 236.4462 crores during the period ended June 30, 2022 as compared to Rs. 235.6472 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 20.1526 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 27.9433 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 8.06 for the period ended June 30, 2022 as compared to Rs. 11.19 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 236.4462 crs	₹235.6472 crs	0.34%
Net Profit	₹20.1526 crs	₹27.9433 crs	-27.88%
EPS	₹8.06	₹11.19	-27.97%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 236.4462 crores during the period ended June 30, 2022 as compared to Rs.178.3018 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.20.1526 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.10.2433 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.8.06 for the period ended June 30, 2022 as compared to Rs.4.10 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 236.4462 crs	₹178.3018 crs	32.61%
Net Profit	₹20.1526 crs	₹10.2433 crs	96.74%
EPS	₹8.06	₹4.10	96.59%

Shares of AstraZeneca Pharma India Limited was last trading in BSE at Rs. 3052.00 as compared to the previous close of Rs. 3096.00. The total number of shares traded during the day was 338 in over 141 trades.

The stock hit an intraday high of Rs. 3102.40 and intraday low of 3022.00. The net turnover during the day was Rs. 1031410.00.

Source : Equity Bulls

Keywords

AstraZenecaPharmaIndia Q1FY23 ResultUpdate